富通科技(00465.HK)與國家心血管疾病臨牀醫學研究中心簽署戰略合作協議
格隆匯12月18日丨富通科技(00465.HK)公告,公司全資附屬公司北京富通東方科技有限公司於2019年12月13日與國家心血管疾病臨牀醫學研究中心簽署了戰略合作協議,雙方將充分利用自身的經驗和資源優勢,在心血管疾病相關的新型應用服務系統方面開展合作,共建心血管疾病領域的智能化平台;以及在心血管疾病、臨牀研究及綜合管理領域等諸多方面開展基於人工智能大數據技術的合作,促進科研成果轉化及產業化。
國家心血管臨牀醫學研究中心心臟內外科診治規模位居全球第二位,是心血管疾病診療新技術的孵化應用評價基地和全國最大的心血管專科人材培養基地之一,擁有大批臨牀研究的領軍人物、學科帶頭人和技術骨幹。
富通東方在人工智能領域持續投入研發,建立先進的數據中心及完善的配套設施,並擁有一支由國內知名大學博士、碩士組成的人工智能產品研發和技術服務團隊。
董事會相信,此次與國家心血管疾病臨牀醫學研究中心的合作,將進一步加強該集團在人工智能和醫療健康領域的技術能力,為客户提供專業化的解決方案及服務。董事會認為,戰略合作協議項下擬進行的合作乃於該公司一般及日常業務過程中訂立,而戰略合作協議的條款經公平磋商,符合一般商業條款,屬公平合理,並符合公司及其股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.